This Week
  • The Market at I-Square is a milestone for the $18 million project in Irondequoit.

  • Leonard Brock grew up very poor and tries to help others in need.

  • Pharos Systems International has grown to become a multinational enterprise.

  • For employees today, paid leave is one of the most important benefits.

  • New Simon School dean Andrew Ainslie has a plan to raise its national stature.

  • The RBJ 75 supplement presents a list of the 75 largest private-sector employers.

Legislation targets toxic algal blooms, awaits Obama OK

Rochester Business Journal
June 18, 2014

Legislation designed to stop the spread of algal blooms in New York’s waterways has been passed by Congress and awaits approval by President Obama, officials announced Wednesday.

The Harmful Algal Blooms and Hypoxia Research and Control Amendment Act was passed Tuesday by the Senate, Sen. Kirsten Gillibrand said. The bill already had passed through the House of Representatives.

“New York’s vast water systems help drive our economy, offer miles of recreation, attract tourists and provide clean drinking water for millions of families,” Gillibrand said in a statement.

The Senate passed a similar bill in February. It was amended in the House, leading to the Senate’s passing of the final version this week.

The legislation stipulates that a task force complete an assessment of hypoxia and algal blooms in the Great Lakes no later than 18 months after the bill becomes law.

It requires that a plan to reduce, mitigate and control Great Lakes hypoxia and algal blooms be submitted no later than two years after the law passes.

Algal blooms are a problem throughout the state, Gillibrand said, resulting in beach and lake closures and damaged fish habitats.

The state Department of Environmental Conservation issued blue-green algae notices for 76 New York lakes in 2013, she said.

Blue-green algae are a form of algal bloom with an unpleasant appearance and odor. It is particularly troublesome for New York’s fresh-water lakes because it causes illness in humans and animals that come in contact with it, Gillibrand said.

(c) 2014 Rochester Business Journal. To obtain permission to reprint this article, call 585-546-8303 or email service@rbj.net.


What You're Saying 

There are no comments yet. Be the first to add yours!

Post Your Own Comment

 
Username:
Password:

Not registered? Sign up now!
 

To Do   Text Size
Post CommentPost A Comment eMail Size1
View CommentsView All Comments PrintPrint Size2
ReprintsReprints Size3
  • E-mailed
  • Commented
  • Viewed
RBJ   Google